NM_017780.4:c.1735C>G
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_017780.4(CHD7):c.1735C>G(p.Gln579Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000000686 in 1,457,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q579K) has been classified as Uncertain significance.
Frequency
Consequence
NM_017780.4 missense
Scores
Clinical Significance
Conservation
Publications
- CHARGE syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Broad Center for Mendelian Genomics, ClinGen, G2P
- hypogonadotropic hypogonadism 5 with or without anosmiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hypogonadotropic hypogonadismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Kallmann syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Omenn syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_017780.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CHD7 | NM_017780.4 | MANE Select | c.1735C>G | p.Gln579Glu | missense | Exon 3 of 38 | NP_060250.2 | ||
| CHD7 | NM_001316690.1 | c.1716+19C>G | intron | N/A | NP_001303619.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CHD7 | ENST00000423902.7 | TSL:5 MANE Select | c.1735C>G | p.Gln579Glu | missense | Exon 3 of 38 | ENSP00000392028.1 | ||
| CHD7 | ENST00000524602.5 | TSL:1 | c.1716+19C>G | intron | N/A | ENSP00000437061.1 | |||
| CHD7 | ENST00000525508.1 | TSL:5 | c.1735C>G | p.Gln579Glu | missense | Exon 2 of 12 | ENSP00000436027.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000409 AC: 1AN: 244534 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1457798Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 724804 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1735C>G (p.Q579E) alteration is located in exon 3 (coding exon 2) of the CHD7 gene. This alteration results from a C to G substitution at nucleotide position 1735, causing the glutamine (Q) at amino acid position 579 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
CHARGE syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at